- Investing Ideas
- Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
17
Companies with a Value score of at least 3, ordered by Value score
17 companies
Gilead Sciences
Market Cap: AR$163.5b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
AR$51,475.00
7D
0.8%
1Y
40.7%
Bristol-Myers Squibb
Market Cap: US$130.0b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMYD
US$22.22
7D
0.6%
1Y
45.7%
Amgen
Market Cap: US$220.5b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGND
US$13.95
7D
4.7%
1Y
48.4%
Bristol-Myers Squibb
Market Cap: AR$130.0b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
AR$33,700.00
7D
-0.3%
1Y
68.1%
Bayer
Market Cap: AR$22.5b
Operates as a life science company worldwide.
BAYN
AR$3,323.26
7D
0%
1Y
n/a
Amgen
Market Cap: AR$220.5b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
AR$21,330.00
7D
6.0%
1Y
69.3%
Novo Nordisk
Market Cap: US$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVOD
US$6.82
7D
-10.5%
1Y
n/a
GSK
Market Cap: US$76.8b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSKD
US$13.39
7D
-7.2%
1Y
45.7%
Novo Nordisk
Market Cap: AR$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVO
AR$10,320.00
7D
-9.9%
1Y
n/a
Gilead Sciences
Market Cap: US$163.5b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDD
US$33.39
7D
1.4%
1Y
22.8%
GSK
Market Cap: AR$77.6b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
AR$20,510.00
7D
0.9%
1Y
63.4%
Tempus AI
Market Cap: AR$8.5b
Operates as a healthcare technology company in the United States.
TEM
AR$6,145.00
7D
12.4%
1Y
-0.9%
AstraZeneca
Market Cap: AR$183.8b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
AR$63,425.00
7D
-5.4%
1Y
28.1%
Novartis
Market Cap: US$236.6b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVSD
US$39.72
7D
-3.5%
1Y
33.3%
Novartis
Market Cap: AR$237.9b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS
AR$60,950.00
7D
-1.6%
1Y
58.0%
Tempus AI
Market Cap: US$8.5b
Operates as a healthcare technology company in the United States.
TEMD
US$4.08
7D
13.2%
1Y
n/a
AstraZeneca
Market Cap: US$183.8b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZND
US$41.70
7D
-7.7%
1Y
12.1%